---
#########################################
# options for knitting a single chapter #
#########################################
output:
  bookdown::html_document2: default
  bookdown::word_document2: default
  bookdown::pdf_document2:
    template: templates/brief_template.tex
documentclass: book
---

# Individual participant data meta-analysis {#ipd-heading}
\minitoc <!-- this will include a mini table of contents-->

## Data sources

As part of this Chapter, I will use individual patient data from a range of sources. These sources are described here in detail for reference.

Should also include a list of reasons why specific additional cohorts were not included - some like the EHR might be too big to get

Each should have: 

* Description (including observation period, numbers, numbers with outcome, etc)
* Whether they are a known genetically at-risk cohort
*

### Epic Norfolk

The European Prospective Investigation of Cancer - Norfolk is a  [@riboli1997; @riboli2002]


```{r tests, }

```


Different approaches to combining subgroups. [@fisher2017]

## Discussion

Letters sent to all cohorts identified through the 

This is likely due to my junior position as a early a

Range of reasons why data is not made available.

Unfortunately, 




As part of this, 

As part of this, an analysis of 
